These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38789343)

  • 1. Coronary microvascular dysfunction and cancer therapy-related cardiovascular toxicity.
    Chitturi KR; Bhogal S; Kassaian SE; Merdler I; Abusnina W; Chaturvedi A; Ben-Dor I; Waksman R; Case BC; Barac A; Hashim HD
    Cardiovasc Revasc Med; 2024 May; ():. PubMed ID: 38789343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.
    Lee SH; Shin D; Lee JM; van de Hoef TP; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung JH; Mejia-Renteria H; Hoshino M; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Murai T; Marques K; Doh JH; Christiansen EH; Banerjee R; Kim HK; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Chamuleau SAJ; van Royen N; Knaapen P; Koo BK; Kakuta T; Escaned J; Piek JJ;
    J Am Heart Assoc; 2022 May; 11(9):e025171. PubMed ID: 35475358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Microvascular Dysfunction.
    Vancheri F; Longo G; Vancheri S; Henein M
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32899944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary electrocardiogram detects coronary microvascular dysfunction and ischemia in patients with no obstructive coronary arteries disease.
    Cevik E; Tas A; Demirtakan ZG; Damman P; Alan Y; Broyd CJ; Ozcan A; Simsek DH; Sonsoz MR; Royen NV; Perera D; Davies JE; Umman S; Sezer M
    Am Heart J; 2024 Apr; 270():62-74. PubMed ID: 38278503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of coronary microvascular dysfunction on the discordance between fractional flow reserve and resting full-cycle ratio in patients with chronic coronary syndromes.
    Legutko J; Niewiara L; Guzik B; Szolc P; Podolec J; Nosal M; Diachyshyn M; Zmudka K; Kleczynski P
    Front Cardiovasc Med; 2022; 9():1003067. PubMed ID: 36277746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary microvascular dysfunction in Takotsubo syndrome and associations with left ventricular function.
    Ekenbäck C; Nickander J; Jokhaji F; Tornvall P; Engblom H; Spaak J; Persson J
    ESC Heart Fail; 2023 Aug; 10(4):2395-2405. PubMed ID: 37218383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve.
    Gallinoro E; Paolisso P; Candreva A; Bermpeis K; Fabbricatore D; Esposito G; Bertolone D; Fernandez Peregrina E; Munhoz D; Mileva N; Penicka M; Bartunek J; Vanderheyden M; Wyffels E; Sonck J; Collet C; De Bruyne B; Barbato E
    Front Cardiovasc Med; 2021; 8():765071. PubMed ID: 34738020
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA.
    Mohammed AA; Zhang H; Abdu FA; Liu L; Singh S; Lv X; Shi T; Mareai RM; Mohammed AQ; Yin G; Zhang W; Xu Y; Che W
    Clin Cardiol; 2023 Feb; 46(2):204-213. PubMed ID: 36567512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of hemodynamic indices of conjunctival microvascular function in patients with coronary microvascular dysfunction.
    Mailey JA; Moore JS; Brennan PF; Jing M; Awuah A; McLaughlin JAD; Nesbit MA; Moore TCB; Spence MS
    Microvasc Res; 2023 May; 147():104480. PubMed ID: 36690270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of combined coronary angiography-derived IMR and myocardial perfusion imaging by CZT SPECT in INOCA.
    Liu L; Dai N; Yin G; Zhang W; Mohammed AQ; Xu S; Lv X; Shi T; Feng C; Mohammed AA; Mareai RM; Xu Y; Yu X; Abdu FA; Yu F; Che W
    J Nucl Cardiol; 2023 Apr; 30(2):684-701. PubMed ID: 35918592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic Coronary Slow Flow Is Not a Valid Surrogate for Invasively Diagnosed Coronary Microvascular Dysfunction.
    Mayer M; Allan T; Harkin KL; Loftspring E; Saffari SE; Reynolds HR; Paul J; Kalathiya R; Shah AP; Nathan S; McCarthy MC; Smilowitz NR; Miner SES; Blair J
    JACC Cardiovasc Interv; 2024 Apr; 17(7):920-929. PubMed ID: 38599696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Microcirculatory Dysfunction on the Resting Full Cycle Ratio Compared to Fractional Flow Reserve.
    Trøan J; Hansen KN; Noori M; Ellert-Gregersen J; Junker A; Veien KT; Hougaard M; Fallesen CO; Hansen HS; Jensen LO
    Cardiovasc Revasc Med; 2023 Sep; 54():41-46. PubMed ID: 37045636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: assessment and management of myocardial infarction and non-obstructive coronary arteries (MINOCA): the role of microvascular coronary vasospasm.
    Marpuri R; Joung S; Gadh A; Dhawan S; Al-Badri A; Pacheco C; Wei J; Merz CNB
    Cardiovasc Diagn Ther; 2019 Aug; 9(4):400-405. PubMed ID: 31555546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Microvascular Blood Volume as a Driver of Coronary Microvascular Disease in Patients With Non-obstructive Coronary Artery Disease: Rationale and Design of the MICORDIS Study.
    Vink CEM; van de Hoef TP; Götte MJW; Eringa EC; Appelman Y
    Front Cardiovasc Med; 2021; 8():730810. PubMed ID: 34660730
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Focus on Coronary Microvascular Dysfunction and Genetic Susceptibility.
    Severino P; D'Amato A; Prosperi S; Myftari V; Colombo L; Tomarelli E; Piccialuti A; Di Pietro G; Birtolo LI; Maestrini V; Badagliacca R; Sardella G; Fedele F; Vizza CD; Mancone M
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cardiac PET in diagnosis and prognosis of patients with ischemia with no obstructive coronary arteries (INOCA).
    Al-Mallah MH; Nayfeh M; Alrifai M
    Am Heart J Plus; 2024 Jul; 43():100399. PubMed ID: 38828445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond Coronary Artery Disease: Assessing the Microcirculation.
    Pruthi S; Siddiqui E; Smilowitz NR
    Interv Cardiol Clin; 2023 Jan; 12(1):119-129. PubMed ID: 36372455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FT4/FT3 ratio: A novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients.
    Zhang H; Che W; Shi K; Huang Y; Xu C; Fei M; Fan X; Zhang J; Hu X; Hu F; Qin S; Zhang X; Huang Q; Yu F
    Front Endocrinol (Lausanne); 2022; 13():1021326. PubMed ID: 36187090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary microvascular dysfunction as assessed by angiography-derived index of microvascular resistance co-localizes with and may explain the presence of ischemia in stress-cardiac magnetic resonance imaging in the absence of coronary artery disease.
    Milzi A; Dettori R; Lubberich RK; Burgmaier K; Marx N; Reith S; Burgmaier M
    Front Cardiovasc Med; 2022; 9():1060764. PubMed ID: 36505374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of Thrombolysis in Myocardial Infarction Frame Count to Invasively Measured Coronary Physiologic Indexes.
    Yamazaki T; Saito Y; Yamashita D; Kitahara H; Kobayashi Y
    Am J Cardiol; 2024 Jan; 211():282-286. PubMed ID: 37980999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.